Silence Therapeutics plc (SLN) Balance Sheet
As of 2026-06-30 (10-Q), Silence Therapeutics plc (SLN) reported total assets of $106.4M, total liabilities of $67.9M and shareholders' equity of $38.5M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $72.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SLNSilence Therapeutics plcFollow SLN — free
—
Price chart with a free account
- Market cap
- 929.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|
| Cash and equivalents | 68.8 | 121.3 | 11.3 | 72.1 | |
| Short-term investments | — | 26.0 | 73.8 | 0.0 | |
| Receivables | 0.3 | 1.0 | 0.0 | — | |
| Current assets | 103.2 | 187.4 | 118.7 | 94.3 | |
| Total assets | 119.4 | 202.6 | 131.4 | 106.4 | |
| Current liabilities | 22.3 | 16.8 | 13.6 | 12.7 | |
| Total liabilities | 97.5 | 68.6 | 69.1 | 67.9 | |
| Shareholders' equity | 22.0 | 134.0 | 62.3 | 38.5 |
USD millions · SEC XBRL
Silence Therapeutics plc — questions
- How much cash does Silence Therapeutics plc have?
- $72.1M in cash and cash equivalents as of 2026-06-30.
- What are Silence Therapeutics plc's total assets?
- $106.4M as of 2026-06-30.
- What is Silence Therapeutics plc's shareholders' equity?
- $38.5M as of 2026-06-30.
Every figure on this page comes from Silence Therapeutics plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.